Rakuten Securities, Inc.
Broker-DealerPosition in KRYS — Krystal Biotech, Inc.
CIK 2009539
TOKYO, M0
Position in KRYS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$7,805
+$7,559 QoQ
Shares Held
21
+2000.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#370
of 419 holders
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KRYS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Rakuten Securities, Inc. holds $795,216 across 27 Biotechnology names. KRYS ranks #12 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
3,543 | $248,116 | |
| 2 | LEGN |
Legend Biotech Corp
|
8,005 | $231,184 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
350 | $65,548 | |
| 4 | CRSP |
CRISPR Therapeutics AG
|
731 | $39,868 | |
| 5 | BNTX |
BioNTech SE
|
416 | $38,708 | |
| 6 | RPRX |
Royalty Pharma plc
|
561 | $31,455 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
115 | $27,711 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
30 | $16,108 |
All Filings in KRYS
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,805 | 21 | Shares | Defined | 2026-08-12 | |
| 2025-12-31 | $246 | 1 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $882 | 5 | Shares | Defined | 2025-10-28 | |
| 2025-06-30 | $687 | 5 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $901 | 5 | Shares | Defined | 2025-04-18 | |
| 2024-12-31 | $3,133 | 20 | Shares | Defined | 2025-02-10 | |
| 2024-09-30 | $2,912 | 16 | Shares | Defined | 2024-11-05 | |
| No filing history on record for this holder in this stock. | ||||||